Evidence map›Paper›PMID 33523925›Full record

ArticleScience advances2021

Trabecular bone organoid model for studying the regulation of localized bone remodeling.

Yongkuk Park, Eugene Cheong, Jun-Goo Kwak, Ryan Carpenter, Jae-Hyuck Shim, Jungwoo Lee

Open access · goldAbstract read
In one paragraph

Article in Science advances, 2021. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 79 papers.

0numbers the graph read from it
0cells of the map it votes in
79citing papers in PubMed
6.8field-weighted citation impact, top 2% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

79 citing papers in PubMed, 139 citations in OpenAlex.

  1. Article
  2. Article
  3. Bone organoids and mitochondrial reprogramming.Journal of orthopaedic translation · 2026
    Review
  4. Artificial intelligence virtual bone organoids (AIVBOs).Journal of orthopaedic translation · 2026
    Review
  5. Article
  6. Article
  7. Article
  8. Article
  9. Review
  10. Bone Organoids: A Novel Tool for Modeling and Managing Skeletal Disorders in Diabetes.Advanced science (Weinheim, Baden-Wurttemberg, Germany) · 2026
    Review
  11. Review
  12. Review
  13. Review
  14. Review
  15. Review
  16. Review
  17. Dual-function TA@CaCOJournal of nanobiotechnology · 2025
    Article
  18. Article
  19. Article
  20. Materiobiology in the omics era.Materials today. Bio · 2025
    Review

19 more citing papers are in PubMed but not listed here.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

6 authors at 2 institutions in 1 country.

Yongkuk ParkDepartment of Chemical Engineering, Institute for Applied Life Sciences, University of Massachusetts, Amherst, MA 01003, USA.ORCID 0000-0003-4481-4287
Eugene CheongDepartment of Biochemistry and Molecular Biology, University of Massachusetts, Amherst, MA 01003, USA.ORCID 0000-0001-8031-3258
Jun-Goo KwakMolecular and Cellular Biology Graduate Program, University of Massachusetts, Amherst, MA 01003, USA.ORCID 0000-0001-9527-0940
Ryan CarpenterDepartment of Chemical Engineering, Institute for Applied Life Sciences, University of Massachusetts, Amherst, MA 01003, USA.ORCID 0000-0001-7083-8325
Jae-Hyuck ShimDepartment of Medicine, University of Massachusetts Medical School, Worcester, MA 01655, USA.ORCID 0000-0002-4947-3293
Jungwoo LeeDepartment of Chemical Engineering, Institute for Applied Life Sciences, University of Massachusetts, Amherst, MA 01003, USA. jungwoo@umass.edu.ORCID 0000-0003-2048-2142
University of Massachusetts Amherst · USUniversity of Massachusetts Chan Medical School · US

Funding

Identification of novel regulators governing osteoclast-osteoblast couplingR01AR068983 · NIAMS · WEILL MEDICAL COLL OF CORNELL UNIV · PI SHIM, JAE-HYUCK · 2016 to 2020
$1.9M
Implantable pre-metastatic niche to elucidate the impact of chemotherapy-induced metastatic relapseR01CA237171 · NCI · UNIVERSITY OF MASSACHUSETTS AMHERST · PI LEE, JUNGWOO · 2019 to 2023
$1.8M
Elucidating Essential Components of Bone Marrow MetastasisR00CA163671 · NCI · UNIVERSITY OF MASSACHUSETTS AMHERST · PI LEE, JUNGWOO · 2014 to 2016
$740k
Novel approach to promote bone formation in osteoporosis using bone-homing mesenchymal stem cellsR21AR073331 · NIAMS · WEILL MEDICAL COLL OF CORNELL UNIV · PI SHIM, JAE-HYUCK, TUNG, CHING-HSUAN · 2018 to 2019
$425k
A novel bone-targeting AAV-mediated gene therapy to promote bone formation in osteoporosisR21AR077557 · NIAMS · UNIV OF MASSACHUSETTS MED SCH WORCESTER · PI SHIM, JAE-HYUCK · 2021 to 2022
$403k
NCI NIH HHS R00 CA163671NCI NIH HHS R01 CA237171NIAMS NIH HHS R01 AR068983NIAMS NIH HHS R21 AR073331NIAMS NIH HHS R21 AR077557
6 · The paper itself

Abstract

Trabecular bone maintains physiological homeostasis and consistent structure and mass through repeated cycles of bone remodeling by means of tightly localized regulation. The molecular and cellular processes that regulate localized bone remodeling are poorly understood because of a lack of relevant experimental models. A tissue-engineered model is described here that reproduces bone tissue complexity and bone remodeling processes with high fidelity and control. An osteoid-inspired biomaterial-demineralized bone paper-directs osteoblasts to deposit structural mineralized bone tissue and subsequently acquire the resting-state bone lining cell phenotype. These cells activate and shift their secretory profile to induce osteoclastogenesis in response to chemical stimulation. Quantitative spatial mapping of cellular activities in resting and activated bone surface coculture showed that the resting-state bone lining cell network actively directs localized bone remodeling by means of paracrine signaling and cell-to-cell contact. This model may facilitate further investigation of trabecular bone niche biology.

Indexed as

Cancellous BoneOrganoidsBone and BonesBone RemodelingOsteoblasts

Identifiers

PMID33523925
PMCPMC7817107
OpenAlexW3124307090

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.